BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8720236)

  • 1. Transmission of two pseudorabies virus strains that differ in virulence and virus excretion in groups of vaccinated pigs.
    Bouma A; De Jong MC; Kimman TG
    Am J Vet Res; 1996 Jan; 57(1):43-7. PubMed ID: 8720236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody response to glycoprotein I in maternally immune pigs exposed to a mildly virulent strain of pseudorabies virus.
    van Oirschot JT; Daus F; Kimman TG; van Zaane D
    Am J Vet Res; 1991 Nov; 52(11):1788-93. PubMed ID: 1664670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two pseudorabies virus vaccines, that differ in capacity to reduce virus excretion after a challenge infection, in their capacity of reducing transmission of pseudorabies virus.
    Bouma A; De Jong MC; Kimman TG
    Vet Microbiol; 1997 Feb; 54(2):113-22. PubMed ID: 9057255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombination of pseudorabies virus vaccine strains in swine.
    Henderson LM; Levings RL; Davis AJ; Sturtz DR
    Am J Vet Res; 1991 Jun; 52(6):820-5. PubMed ID: 1652903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
    Kit S; Sheppard M; Ichimura H; Kit M
    Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response of pigs inoculated with virulent pseudorabies virus and pigs inoculated with attenuated or inactivated pseudorabies virus vaccine before and after challenge exposure.
    Kelling CL; Staudinger WL; Rhodes MB
    Am J Vet Res; 1982 Dec; 43(12):2114-20. PubMed ID: 6299139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccination against pseudorabies with glycoprotein gI+ or glycoprotein gI- vaccine.
    Vandeputte J; Chappuis G; Fargeaud D; Précausta P; Guillemin F; Brun A; Desmettre P; Stellmann C
    Am J Vet Res; 1990 Jul; 51(7):1100-6. PubMed ID: 2167620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of specific humoral immune response in pigs vaccinated intradermally with deleted Aujeszky's disease vaccine and challenged with virulent strain of Herpesvirus suis type 1.
    Mikulska-Skupień E; Szweda W; Procajło Z
    Pol J Vet Sci; 2005; 8(1):11-6. PubMed ID: 15794468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of memory B-cell responses in serum and mucosal fluids of swine for protective immunity against pseudorabies virus.
    Kimman TG; Oei-Lie N; van Zaane D
    Am J Vet Res; 1992 Nov; 53(11):1992-8. PubMed ID: 1334639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudorabies virus infections in pigs. Role of viral proteins in virulence, pathogenesis and transmission.
    Mulder WA; Pol JM; Gruys E; Jacobs L; De Jong MC; Peeters BP; Kimman TG
    Vet Res; 1997; 28(1):1-17. PubMed ID: 9172836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of swine with thymidine kinase-deficient mutants of pseudorabies virus.
    McGregor S; Easterday BC; Kaplan AS; Ben-Porat T
    Am J Vet Res; 1985 Jul; 46(7):1494-7. PubMed ID: 2992326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes.
    Marchioli CC; Yancey RJ; Wardley RC; Thomsen DR; Post LE
    Am J Vet Res; 1987 Nov; 48(11):1577-83. PubMed ID: 2829665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity.
    Kimman TG; De Wind N; De Bruin T; de Visser Y; Voermans J
    Virology; 1994 Dec; 205(2):511-8. PubMed ID: 7975253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal vaccination of pigs against pseudorabies: absence of vaccinal virus latency and failure to prevent latency of virulent virus.
    van Oirschot JT; Gielkens AL
    Am J Vet Res; 1984 Oct; 45(10):2099-103. PubMed ID: 6093645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a pseudorabies virus vaccine based on deletion mutant strain 783 that does not express thymidine kinase and glycoprotein I.
    van Oirschot JT; Moormann RJ; Berns AJ; Gielkens AL
    Am J Vet Res; 1991 Jul; 52(7):1056-60. PubMed ID: 1654033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation in swine of a subunit vaccine against pseudorabies.
    Maes RK; Schutz JC
    Am J Vet Res; 1983 Jan; 44(1):123-5. PubMed ID: 6297337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a killed gpX deleted pseudorabies virus vaccine.
    Cook DR; Hill HT; Kinker DR
    Can J Vet Res; 1990 Oct; 54(4):438-45. PubMed ID: 2174294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus.
    Kit S; Kit M; Pirtle EC
    Am J Vet Res; 1985 Jun; 46(6):1359-67. PubMed ID: 2992322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shedding patterns in swine of virulent and attenuated pseudorabies virus.
    Maes RK; Kanitz CL; Gustafson DP
    Am J Vet Res; 1983 Nov; 44(11):2083-6. PubMed ID: 6316822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against pseudorabies virus infection by intranasal vaccination of newborn pigs.
    McCaw MB; Xu J
    Am J Vet Res; 1993 Apr; 54(4):527-33. PubMed ID: 8387249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.